Browse diseases

…dy aimed to compare the efficacy of different interventions for myopia control in children, including 0.01% atropine (AP), orthokerato…

…The ‘myopia epidemic’ has become a significant public health concern. Studi…

…was 78.0%, while it was 42.1% in the parents. The prevalence of high myopia (9.6% vs 5.2%) and moderate myopia (38.8% vs 9.9%) was higher i…

…, p>0.05) do not exhibit a causal relationship with the risk of diabetic retinopathy.Conclusion This two-sample Mendelian randomization study provid…

…25% atropine and single vision (SV) spectacle lenses in slowing myopia progression in children with myopia.Methods Randomised controll…

…ns Combining RLRL therapy with ortho-k is an effective and safe myopia control strategy in Caucasian Spanish children, supporting the …

…ed in AL elongation.Conclusion 0.01% atropine effectively slows myopia progression across ethnicities, with the greatest efficacy obse…

…f time outdoors or additional interventions to prevent or delay myopia onset in this population.…

…ocus. Low-dose atropine 0.1–0.5 mg/ml is widely used to prevent myopia progression in children with minimal side effects. In Estonia, …

…LRL therapy provides promising long-term efficacy and safety in myopia control over 3 years among Chinese myopic children and adolesce…

…e randomised clinical trial will enrol 80 eyes from adults with myopia or compound myopic astigmatism within the ranges sphere −0.50 t…

…Myopia is associated with various types of strabismus including concom…